Free provider profile
CRISTINA CUSIN, MD
NPI 1003942426
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2010-03-12.
MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET, BOSTON, MA, 02114
617-726-2066
Single practice location
Enumerated 2007-02-27
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 16 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
619
Medicare patients
32
Part D drug cost
$228,748
Brand-name share
15.5%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Ingrezza (Valbenazine Tosylate) | 13 | $108,736 |
| Trintellix (Vortioxetine Hydrobromide) | 26 | $24,965 |
| Effexor Xr (Venlafaxine Hcl) | 13 | $18,499 |
| Methylphenidate Er (Methylphenidate Hcl) | 30 | $1,346 |
| Bupropion Xl (Bupropion Hcl) | 25 | $1,016 |
| Dextroamphetamine-Amphet Er (Dextroamphetamine/Amphetamine) | 13 | $732 |
| Lamotrigine (Lamotrigine) | 21 | $574 |
| Clonazepam (Clonazepam) | 52 | $573 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202438 sessions · 19 patients · $43,077
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.